Securities Investigation Adds to TruBridge’s Risk Profile

What happened

The Rosen Law Firm has launched an investigation into TruBridge for potential securities law violations, alleging that the company issued materially misleading business information to investors. This legal overhang compounds existing concerns from the DeepValue report, including elevated leverage at 4.65x net debt/EBITDA, declining year-over-year bookings, and un-remediated internal control weaknesses that persisted through mid-2024. While TruBridge’s Q3 2025 results showed improving execution with 94% recurring revenue and positive free cash flow, guidance for Q4 and FY2025 reflects modest growth and the investigation casts doubt on the reliability of management’s forward-looking statements. The stock already trades at an EV/EBITDA of ~13x, well above the DCF intrinsic value of $4.47 per share, leaving little margin for error. Until the investigation clarifies or the company demonstrates sustained deleveraging and control remediation, the risk/reward skews negative.

Implication

In the near term, the investigation introduces significant uncertainty around management credibility and financial reporting accuracy, likely weighing on the stock and potentially triggering further legal costs or settlements. The company’s high leverage (4.65x net debt/EBITDA) and restrictive credit covenants leave limited room to absorb adverse outcomes, and any covenant waiver requests could signal deeper stress. For investors with existing positions, this development argues for de-risking, given that the valuation already appears full relative to the DCF anchor and the investigation may expose additional undisclosed issues. Wait-and-watch investors should let the legal process unfold and look for tangible signs of control remediation and a clear plan to reduce leverage before considering entry. Secular tailwinds in outsourced RCM remain intact, but they do not protect against company-specific governance failures or dilution risk if financing becomes constrained.

Thesis delta

The baseline thesis was a cautious 'WAIT' leaning toward improvement if guidance was met. The securities investigation introduces a hard downside scenario that shifts the probability toward a 'SELL' thesis. Until the investigation is resolved and management reclaims credibility, risk outweighs reward even if operating metrics meet guidance.